A couple years back there was talk of IKNX doing some work with 3D printing (I believe they supply materials to 3D printers). Anybody have any insight as to where they are with that process now? Seems like a good industry in which to participate, for future growth.
Ok, good point and my mistake moneygamer. Thought they used that to raise capital. Anyway, the float remains low so with some good news and price acceleration the shelf could be absorbed. It's ridiculous how many biotechs have floats over $100M shares; these trials take lots of time and money. The drugs have to work at the end of the day and no doubt we will see gains if they succeed.
Disagree, the low float of under 40M shares gives this one room to move up and fast if we get good results in trials. Perkins has been very good in the past about only raising capital at higher prices (I believe they did it in the $40's) and I am hopeful she will continue to be very selective about when to issue new shares.